Literature DB >> 16856149

Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells.

Anna Setzu1, Justin D Lathia, Chao Zhao, Karen Wells, Mahendra S Rao, Charles Ffrench-Constant, Robin J M Franklin.   

Abstract

Inflammation associated with CNS demyelination provides an important stimulus for the activation of endogenous oligodendrocyte precursor cells (OPCs) and subsequent remyelination. This view is largely based on "loss-of-function" studies, whereby remyelination is impaired following depletion of inflammatory cells or mediators. However, "gain-of-function" approaches, asking whether inflammation directly enhances remyelination, have received less attention. We have addressed this issue using a model in which OPCs transplanted into the adult rat retina myelinate retinal ganglion cell axons around the point of injection. Inflammation (characterized by increased expression of the macrophage marker ED1 and the astrocyte marker GFAP, and the up-regulation of multiple cytokines) was induced in the retina by the administration of the TLR-2 ligand zymosan. Myelination, revealed by MBP+ myelin sheaths, was substantially increased when OPCs were injected into the inflamed retina compared to that achieved following transplantation into the normal, noninflamed retina. Our results have important implications for the development of immunomodulatory treatments for acute demyelinating disease and for the therapeutic creation of proremyelination environments in chronic demyelinating disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16856149     DOI: 10.1002/glia.20371

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  62 in total

Review 1.  Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.

Authors:  Tony Wyss-Coray; Joseph Rogers
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

2.  Neuroprotective effect of oligodendrocyte precursor cell transplantation in a long-term model of periventricular leukomalacia.

Authors:  Daniel J Webber; Marka van Blitterswijk; Siddharthan Chandran
Journal:  Am J Pathol       Date:  2009-10-22       Impact factor: 4.307

Review 3.  Immune influence on adult neural stem cell regulation and function.

Authors:  Pamela A Carpentier; Theo D Palmer
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

Review 4.  Cell therapy for multiple sclerosis.

Authors:  Tamir Ben-Hur
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

5.  Tight squeeze, slow burn: inflammation and the aetiology of cervical myelopathy.

Authors:  Michael S Beattie; Geoffrey T Manley
Journal:  Brain       Date:  2011-05       Impact factor: 13.501

Review 6.  The benefits of neuroinflammation for the repair of the injured central nervous system.

Authors:  Heather Y F Yong; Khalil S Rawji; Samira Ghorbani; Mengzhou Xue; V Wee Yong
Journal:  Cell Mol Immunol       Date:  2019-03-15       Impact factor: 11.530

7.  Activation of inflammatory response by a combination of growth factors in cuprizone-induced demyelinated brain leads to myelin repair.

Authors:  Juan Carlos Biancotti; Shalini Kumar; Jean de Vellis
Journal:  Neurochem Res       Date:  2008-07-26       Impact factor: 3.996

8.  Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment.

Authors:  Kevin D Beck; Hal X Nguyen; Manuel D Galvan; Desirée L Salazar; Trent M Woodruff; Aileen J Anderson
Journal:  Brain       Date:  2010-01-19       Impact factor: 13.501

Review 9.  Toll-like receptors in neurodegeneration.

Authors:  Eitan Okun; Kathleen J Griffioen; Justin D Lathia; Sung-Chun Tang; Mark P Mattson; Thiruma V Arumugam
Journal:  Brain Res Rev       Date:  2008-09-12

10.  Myelinated, synapsing cultures of murine spinal cord--validation as an in vitro model of the central nervous system.

Authors:  C E Thomson; M McCulloch; A Sorenson; S C Barnett; B V Seed; I R Griffiths; M McLaughlin
Journal:  Eur J Neurosci       Date:  2008-09-10       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.